What Is Real-World Data (RWD)? A Review of Definitions Based on Literature and Stakeholder Interviews by Makady, Amr, MSc, de Boer, Anthonius, MD, PhD, Hillege, Hans, PhD, Klungel, Olaf, PhD, Goettsch, Wim, PhD

Get full text

Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies by Makady, Amr, MSc, Ham, Renske ten, MSc, de Boer, Anthonius, MD, Hillege, Hans, PhD, Klungel, Olaf, PhD, Goettsch, Wim, PhD

Get full text

Unmet Medical Need: An Introduction to Definitions and Stakeholder Perceptions by Vreman, Rick A., PharmD, Heikkinen, Inkatuuli, MSc, MHEcon, Schuurman, Ad, MSc, MBA, Sapede, Claudine, PharmD, Garcia, Jordi Llinares, PhD, Hedberg, Niklas, PharmD, Athanasiou, Dimitrios, MBA, Grueger, Jens, PhD, Leufkens, Hubert G.M., PhD, Goettsch, Wim G., PhD

Get full text

Improving the Contribution of Regulatory Assessment Reports to Health Technology Assessments—A Collaboration between the European Medicines Agency and the European network for Heal... by Berntgen, Michael, PhD, MDRA, Gourvil, Anne, PhD, Pavlovic, Mira, MD, Goettsch, Wim, PhD, Eichler, Hans-Georg, MD, MSc, Kristensen, Finn Børlum, MD, PhD

Get full text

The HTA Core Model® —10 Years of Developing an International Framework to Share Multidimensional Value Assessment by Kristensen, Finn Børlum, MD, PhD, Lampe, Kristian, MD, Wild, Claudia, DPhil, Cerbo, Marina, MSc, Goettsch, Wim, MSc, PhD, Becla, Lidia, MSc

Get full text

Review: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force by Goettsch, Wim G., PhD, Enzing, Joost, MSc

Get full text

Relative Effectiveness Assessment of Pharmaceuticals: Similarities and Differences in 29 Jurisdictions by Kleijnen, Sarah, MSc, George, Elisabeth, PhD, Goulden, Scott, MSc, d'Andon, Anne, MD, Vitré, Pauline, PD, MSc, Osińska, Boguslawa, MSc, Rdzany, Rafal, PhD, Thirstrup, Steffen, MD, PhD, Corbacho, Belen, MSc, Nagy, Bence Z., MSc, Leufkens, Hubert G., PhD, de Boer, Anthonius, MD, PhD, Goettsch, Wim G., PhD

Get full text

Can a Joint Assessment Provide Relevant Information for National/Local Relative Effectiveness Assessments? An In-Depth Comparison of Pazopanib Assessments by Kleijnen, Sarah, MSc, Fathallah, Mohammed, MSc, van der Linden, Michiel W., MD, PhD, Vancraeynest, Piet, MD, MScBiostat, Dahmani, Bachir, PhD, Timoney, Angela, MSc, MPH, De Boer, Anthonius, MD, PhD, Leufkens, Hubertus G., PharmD, PhD, Goettsch, Wim G., PhD

Get full text

Bridging Trial and Decision: A Checklist to Frame Health Technology Assessments for Resource Allocation Decisions by Grutters, Janneke P.C., PhD, Seferina, Shanly C., MD, Tjan-Heijnen, Vivianne C.G., MD, PhD, van Kampen, Roel J.W., MD, Goettsch, Wim G., PhD, Joore, Manuela A., PhD

Get full text